Progyny, Inc. Enhances Suite of Services with Acquisition of BenefitBump

Provides expecting parents with a concierge-level service model that delivers expert guidance, navigation and support for parental leave planning

NEW YORK, Jan. 28, 2025 (GLOBE NEWSWIRE) — Progyny, Inc. (Nasdaq: PGNY), a transformative fertility, family building, and women’s health benefits solution, today announced the acquisition of BenefitBump, a comprehensive parental leave benefits navigation program for new and growing families. This addition enhances Progyny’s fertility and family building offering, extending the company’s ability to further serve the needs of families on their journey from pregnancy to early childhood and beyond.

With 90% of parents seeking greater support to manage responsibilities at work and home, Progyny’s enhanced suite of solutions aims to reduce member stress, improve recruitment, return-to-work and retention rates, and foster proactive child and family health. By addressing gaps across the spectrum, from fertility to postpartum support and parental leave navigation, the company helps eliminate fragmentation and enhances multi-dimensional outcomes for families.

“The acquisition of BenefitBump extends our ability to provide compassionate and dedicated support to give members more confidence along their parenting journey,” said Pete Anevski, Chief Executive Officer, Progyny. “BenefitBump’s high-touch, guided support integrates seamlessly into our existing patient care model and aligns with our commitment to improving member well-being through a higher standard of care.”

Alongside the offerings Progyny is known for across preconception, fertility, pregnancy, postpartum, and menopause, the enhanced suite of services will include:

  • Clinical social worker-led parental wellness program
  • Comprehensive parental leave and benefits navigation
  • Care and resource navigation for child behavior concerns and neurodiverse care
  • Clinician-facilitated peer support groups

“Navigating employee benefits and leave programs is complex and adds unnecessary stress for families. Every new parent will experience leave, yet it has been an underserved area. BenefitBump was built by listening to the challenges and needs of parents, with the goal of easing their anxiety and ensuring employers and employees get the most value from family support investments,” said Scott Liebman, Founder, BenefitBump. “We’re thrilled to join Progyny, an innovator and leader in the family building space, and together provide the holistic support that families deserve.”

For more information about Progyny visit www.progyny.com.

About Progyny

Progyny (Nasdaq: PGNY) is a transformative fertility, family building and women’s health benefits solution, trusted by the nation’s leading employers, health plans and benefit purchasers. We envision a world where everyone can realize their dreams of family and ideal health. Our outcomes prove that comprehensive, inclusive, and intentionally designed solutions simultaneously benefit employers, patients and physicians. 

Our benefits solution empowers patients with concierge support, coaching, education, and digital tools; provides access to a premier network of fertility and women’s health specialists who use the latest science and technologies; drives optimal clinical outcomes; and reduces healthcare costs.  

Headquartered in New York City, Progyny has been recognized for its leadership and growth as a TIME100 Most Influential Company, CNBC Disruptor 50, Modern Healthcare’s Best Places to Work in Healthcare, Forbes’ Best Employers, Financial Times Fastest Growing Companies, Inc. 5000, Inc. Power Partners, and Crain’s Fast 50 for NYC. For more information, visit www.progyny.com

For Further Information, Please Contact:

Investors:
James Hart
investors@progyny.com

Media:
Alexis Ford
media@progyny.com

Staff

Recent Posts

GaraHerb Supplement Facts, Ingredient Label Details, and Product Disclosures: A 2026 Informational Overview of Male Enhancement Supplement Options

Label-verified GaraHerb ingredient disclosures, manufacturing and policy transparency details, and what consumers searching for GaraHerb…

2 days ago

Cannabix Technologies announces Non-Brokered LIFE Private Placement

  NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES…

2 days ago

LuminEye Nano-Drops Product Information Updated as Consumer Interest in Eye Health Supplement Options and Vision Support Alternatives Grows in 2026

An informational overview examining category context, publicly available product disclosures, and what consumers often consider…

2 days ago

Lexicon Announces Closing of Approximately $94.6 Million Public Offering and Concurrent Private Placement

THE WOODLANDS, Texas, Feb. 06, 2026 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) (“Lexicon”)…

2 days ago

Laughland Teeth Whitening Kit: Ingredients, Disclosures, and What Consumers Are Researching in 2026

A 2026 informational overview of the Laughland whitening kit covering publicly available ingredient disclosures, product…

2 days ago